Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microtubule crosslinking factor 1 (MTCL1) is a large, coiled-coil cytoskeletal protein that plays a dual role in directly crosslinking and stabilizing microtubules in non-centrosomal arrays, such as those found around the Golgi apparatus and in polarized epithelial cells[1][3]. MTCL1 acts as a dimer and possesses two distinct microtubule-binding domains: the N-terminal domain crosslinks microtubules without affecting dynamics, while the C-terminal domain stabilizes microtubules and facilitates bundled microtubule assemblies[1][3]. MTCL1 is essential for the formation and maintenance of the perinuclear microtubule network that supports Golgi ribbon morphology, and is critical for the structural integrity of Purkinje neuron axons and apico-basal polarity in epithelial cells[1][3][4]. Currently, MTCL1 is not a recognized therapeutic target, and there are no known drugs or drug mechanisms that specifically target this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule crosslinking factor 1 (MTCL1).